Pier Luigi Luigi Zinzani (Pierluigi Luigi Zinzani, P L Zinzani, PierLuigi Zinzani, Pier L Zinzani, Pierluigi Zinzani, Pier Luigi Zinzani, Pier-Luigi Zinzani)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 163

Top Venues

Blood advances

Hematological oncology

Leukemia

Blood

This page only lists publications with an associated author ORCID identifier.

Publications

Chiara De Philippis, Cristina Zucchinetti, Daniele Mannina, Mauro Krampera, Pier Luigi Luigi Zinzani, Annalisa Chiappella, Alice di Rocco, Enrico Orcioulo, Maria Chiara Tisi, Flavio Pistolese, Laura Giordano, Armando Santoro, Stefania Bramanti
Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma. Bone marrow transplantation 59 (4) (2024)
Martin Dreyling, Nathan Hale Fowler, Michael J Dickinson, Joaquin Martinez Lopez, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie L Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A Riedell, P Joy Ho, José Antonio Pérez-Simón, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh O'Donovan, Roberto Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update. Blood 143 (17) (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Annalisa Chiappella, Beatrice Casadei, Patrizia Chiusolo, Alice Di Rocco, Silva Ljevar, Martina Magni, Piera Angelillo, Anna Maria Barbui, Ilaria Cutini, Anna Dodero, Francesca Bonifazi, Maria Chiara Tisi, Stefania Bramanti, Maurizio Musso, Mirko Farina, Massimo Martino, Mattia Novo, Giovanni Grillo, Francesca Patriarca, Giulia Zacchi, Mauro Krampera, Martina Pennisi, Eugenio Galli, Maurizio Martelli, Andrés José Maria Ferreri, Silvia Ferrari, Riccardo Saccardi, Anisa Bermema, Anna Guidetti, Rosalba Miceli, Pier Luigi Luigi Zinzani, Paolo Corradini
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study. Leukemia 38 (5) (2024)
Camilla Mazzoni, Lisa Argnani, Beatrice Casadei, Alessandro Broccoli, Giulia Gabrielli, Nicole Fabbri, Gabriele Gugliotta, Cinzia Pellegrini, Matteo Carella, Gianmarco Bagnato, Marianna Gentilini, Alice Morigi, Pierluca Maglio, Martina Cantelli, Vittorio Stefoni, Pier Luigi Luigi Zinzani
Efficacy and Safety of Frontline Single-Agent Rituximab in Extranodal Marginal Zone Lymphoma. European journal of haematology (2024)
Annalisa Chiappella, Beatrice Casadei, Patrizia Chiusolo, Alice Di Rocco, Silva Ljevar, Martina Magni, Piera Angelillo, Anna Maria Barbui, Ilaria Cutini, Anna Dodero, Francesca Bonifazi, Maria Chiara Tisi, Stefania Bramanti, Maurizio Musso, Mirko Farina, Massimo Martino, Mattia Novo, Giovanni Grillo, Francesca Patriarca, Giulia Zacchi, Mauro Krampera, Martina Pennisi, Eugenio Galli, Maurizio Martelli, Andrés José Maria Ferreri, Silvia Ferrari, Riccardo Saccardi, Anisa Bermema, Anna Guidetti, Rosalba Miceli, Pier Luigi Luigi Zinzani, Paolo Corradini
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study. Leukemia 38 (5) (2024)
Chiara De Philippis, Cristina Zucchinetti, Daniele Mannina, Mauro Krampera, Pier Luigi Luigi Zinzani, Annalisa Chiappella, Alice di Rocco, Enrico Orcioulo, Maria Chiara Tisi, Flavio Pistolese, Laura Giordano, Armando Santoro, Stefania Bramanti
Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma. Bone marrow transplantation (2024)
Martin Dreyling, Nathan Hale Fowler, Michael J Dickinson, Joaquin Martinez Lopez, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie L Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A Riedell, P Joy Ho, José Antonio Pérez-Simón, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh O'Donovan, Roberto Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update. Blood 143 (17) (2024)
Annalisa Chiappella, Beatrice Casadei, Patrizia Chiusolo, Alice Di Rocco, Silva Ljevar, Martina Magni, Piera Angelillo, Anna Maria Barbui, Ilaria Cutini, Anna Dodero, Francesca Bonifazi, Maria Chiara Tisi, Stefania Bramanti, Maurizio Musso, Mirko Farina, Massimo Martino, Mattia Novo, Giovanni Grillo, Francesca Patriarca, Giulia Zacchi, Mauro Krampera, Martina Pennisi, Eugenio Galli, Maurizio Martelli, Andrés José Maria Ferreri, Silvia Ferrari, Riccardo Saccardi, Anisa Bermema, Anna Guidetti, Rosalba Miceli, Pier Luigi Luigi Zinzani, Paolo Corradini
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study. Leukemia 38 (5) (2024)
Michael R Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji, Jacqueline Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Claire Dearden, Sascha Dietrich, Monica Else, Narendranath Epperla, Andrei Fagarasanu, Brunangelo Falini, Francesco Forconi, Alessandro Gozzetti, Paul Joseph Hampel, David J Hermel, Sunil Iyengar, James B Johnston, Gunnar Juliusson, Robert J Kreitman, Francesco Lauria, Gerard Lozanski, Christopher C Oakes, Sameer A Parikh, Jae H Park, Graeme Quest, Kanti R Rai, Farhad Ravandi, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Enrico Tiacci, Xavier Troussard, Bernhard J Woermann, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani
Hairy cell leukemia variant and WHO classification correspondence Re: 5 th edition WHO classification haematolymphoid tumors: lymphoid neoplasms. Leukemia 38 (7) (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Antonello Pinto, M Caltagirone, M Battista, G C Gazzoli, C Patti, E Pennese, S De Lorenzo, V Pavone, Michele Merli, A Chiarenza, A G Gorgone, F Piazza, B Puccini, A Noto, Luca Arcaini, R De Filippi, Pier Luigi Luigi Zinzani, A J M Ferreri, M Ladetto, S Ferrari, G Gritti
Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma. British journal of haematology (2024)
Federico Stella, Annalisa Chiappella, Beatrice Casadei, Stefania Bramanti, Silva Ljevar, Patrizia Chiusolo, Alice Di Rocco, Maria Chiara Tisi, Matteo Giovanni Giovanni Carrabba, Ilaria Cutini, Massimo Martino, Anna Dodero, Francesca Bonifazi, Armando Santoro, Federica Sorà, Barbara Botto, Anna Maria Barbui, Domenico Russo, Maurizio Musso, Giovanni Grillo, Mauro Krampera, Jacopo Olivieri, Marco Ladetto, Federica Cavallo, Massimo Massaia, Luca Arcaini, Martina Pennisi, Pier Luigi Luigi Zinzani, Rosalba Miceli, Paolo Corradini
A multi-center real-life prospective study of axicabtagene ciloleucel versus tisagenlecleucel toxicity and outcomes in Large B-Cell Lymphomas. Blood cancer discovery (2024)
Criscuolo Marianna, Maria Elena Tosti, Alessandro Broccoli, Marzia Varettoni, Alessio Maria Edoardo Maraglino, Antonella Anastasia, Maria Cantonetti, Livio Trentin, Sofia Kovalchuk, Lorella Orsucci, Marina Deodato, Angelica Spolzino, Stefano Volpetti, Ombretta Annibali, Sergio Storti, Caterina Stelitano, Francesco Marchesi, Sonia Morè, Luana Fianchi, Brunangelo Falini, Alessandro Pulsoni, Enrico Tiacci, Pier Luigi Luigi Zinzani, Livio Pagano
Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review. Cancers 16 (8) (2024)
Alessandro Broccoli, Lisa Argnani, Gabriele Gugliotta, Cinzia Pellegrini, Beatrice Casadei, Gianmarco Bagnato, Marianna Gentilini, Vittorio Stefoni, Pier Luigi Luigi Zinzani
The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous Transplantation. The oncologist 29 (6) (2024)
Alessandro Broccoli, Lisa Argnani, Gabriele Gugliotta, Cinzia Pellegrini, Beatrice Casadei, Gianmarco Bagnato, Marianna Gentilini, Vittorio Stefoni, Pier Luigi Luigi Zinzani
The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous Transplantation. The oncologist (2024)
Julia Driessen, Fer de Wit, Alex F Herrera, Pier Luigi Luigi Zinzani, Ann Steward LaCasce, Peter D Cole, Craig H Moskowitz, Miriam Santero, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée J M Zijlstra-Baalbergen, Barbara A Hutten, Alison J Moskowitz, Marie José Kersten
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis. Blood advances 8 (11) (2024)
Antonio Pinto, Marco Ladetto, Maurizio Martelli, Carlo Visco, Francesco Zaja, Emanuele Guardalben, Pier Luigi Luigi Zinzani
Unmet needs in relapsed/refractory mantle cell lymphoma after failure of covalent Bruton's tyrosine kinase inhibitors: An Italian scenario. Hematological oncology 42 (1) (2024)
Federico Stella, Annalisa Chiappella, Beatrice Casadei, Stefania Bramanti, Silva Ljevar, Patrizia Chiusolo, Alice Di Rocco, Maria Chiara Tisi, Matteo Giovanni Giovanni Carrabba, Ilaria Cutini, Massimo Martino, Anna Dodero, Francesca Bonifazi, Armando Santoro, Federica Sorà, Barbara Botto, Anna Maria Barbui, Domenico Russo, Maurizio Musso, Giovanni Grillo, Mauro Krampera, Jacopo Olivieri, Marco Ladetto, Federica Cavallo, Massimo Massaia, Luca Arcaini, Martina Pennisi, Pier Luigi Luigi Zinzani, Rosalba Miceli, Paolo Corradini
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas. Blood cancer discovery 5 (5) (2024)
Julia Driessen, Fer de Wit, Alex F Herrera, Pier Luigi Luigi Zinzani, Ann Steward LaCasce, Peter D Cole, Craig H Moskowitz, Miriam Santero, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée J M Zijlstra-Baalbergen, Barbara A Hutten, Alison J Moskowitz, Marie José Kersten
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis. Blood advances 8 (11) (2024)
Michael R Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji, Jacqueline Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Claire Dearden, Sascha Dietrich, Monica Else, Narendranath Epperla, Andrei Fagarasanu, Brunangelo Falini, Francesco Forconi, Alessandro Gozzetti, Paul Joseph Hampel, David J Hermel, Sunil Iyengar, James B Johnston, Gunnar Juliusson, Robert J Kreitman, Francesco Lauria, Gerard Lozanski, Christopher C Oakes, Sameer A Parikh, Jae H Park, Graeme Quest, Kanti R Rai, Farhad Ravandi, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Enrico Tiacci, Xavier Troussard, Bernhard J Woermann, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani
Hairy cell leukemia variant and WHO classification correspondence Re: 5 th edition WHO classification haematolymphoid tumors: lymphoid neoplasms. Leukemia 38 (7) (2024)
Alessandro Broccoli, Lisa Argnani, Gabriele Gugliotta, Cinzia Pellegrini, Beatrice Casadei, Gianmarco Bagnato, Marianna Gentilini, Vittorio Stefoni, Pier Luigi Luigi Zinzani
The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous Transplantation. The oncologist 29 (6) (2024)
Martin Dreyling, Nathan H Fowler, Michael J Dickinson, Joaquín Martínez-López, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Babis Andreadis, Peter A Riedell, P Joy Ho, Jose Antonio Perez-Simon, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh Stephen O'Donovan, Roberto Javier Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable Response After Tisagenlecleucel in Adults With Relapsed/Refractory Follicular Lymphoma: ELARA Trial Update. Blood (2024)
Julia Driessen, Fer de Wit, Alex F Herrera, Pier Luigi Luigi Zinzani, Ann Steward LaCasce, Peter D Cole, Craig H Moskowitz, Miriam Santero, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée J M Zijlstra-Baalbergen, Barbara A Hutten, Alison J Moskowitz, Marie José Kersten
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis. Blood advances 8 (11) (2024)
Arianna Catelli, Cristina Nanni, Rita Mulè, Pier Luigi Luigi Zinzani, Sabattini Elena, Marcello Lanari, Francesca Conti
The Dark Side of Activated Phosphoinositide 3-Kinase-δ Syndrome 2: A Story Rewritten through FDG-PET. Journal of clinical medicine 13 (8) (2024)
Julia Driessen, Fer de Wit, Alex F Herrera, Pier Luigi Luigi Zinzani, Ann Steward LaCasce, Peter D Cole, Craig H Moskowitz, Miriam Santero, Michael Fuchs, Horst Mueller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée J M Zijlstra-Baalbergen, Barbara A Hutten, Alison J Moskowitz, Marie José Kersten
Brentuximab Vedotin and Chemotherapy in Relapsed/Refractory Hodgkin Lymphoma: a Propensity Score Matched Analysis. Blood advances (2024)
Martin Dreyling, Nathan H Fowler, Michael J Dickinson, Joaquín Martínez-López, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Babis Andreadis, Peter A Riedell, P Joy Ho, Jose Antonio Perez-Simon, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh Stephen O'Donovan, Roberto Javier Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable Response After Tisagenlecleucel in Adults With Relapsed/Refractory Follicular Lymphoma: ELARA Trial Update. Blood (2024)
Michael R Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji, Jacqueline Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Claire Dearden, Sascha Dietrich, Monica Else, Narendranath Epperla, Andrei Fagarasanu, Brunangelo Falini, Francesco Forconi, Alessandro Gozzetti, Paul Joseph Hampel, David J Hermel, Sunil Iyengar, James B Johnston, Gunnar Juliusson, Robert J Kreitman, Francesco Lauria, Gerard Lozanski, Christopher C Oakes, Sameer A Parikh, Jae H Park, Graeme Quest, Kanti R Rai, Farhad Ravandi, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Enrico Tiacci, Xavier Troussard, Bernhard J Woermann, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani
Hairy cell leukemia variant and WHO classification correspondence Re: 5 th edition WHO classification haematolymphoid tumors: lymphoid neoplasms. Leukemia 38 (7) (2024)
Beatrice Casadei, Gabriele Conti, Monica Barone, Silvia Turroni, Serafina Guadagnuolo, Alessandro Broccoli, Patrizia Brigidi, Lisa Argnani, Pier Luigi Luigi Zinzani
Role of gut microbiome in the outcome of lymphoma patients treated with checkpoint inhibitors-The MicroLinf Study. Hematological oncology 42 (5) (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Pier Luigi Luigi Zinzani, Huaqing Wang, Jifeng Feng, Tae Min Kim, Rong Tao, Huilai Zhang, Laura Maria Fogliatto, Clara Maluquer Artigal, Muhit Özcan, Eduardo Patricio Yanez Ruiz, Won Seog Kim, Dmitry Kirtbaya, Iryna Kriachok, Felipe Maciel, Hongwei Xue, Krimo Bouabdallah, Charles Phelps, Shalini Chaturvedi, Anke Weispfenning, Peter N Morcos, Fatuma Catherine Atieno Odongo, Viktoriya Buvaylo, Barrett H Childs, Martin Dreyling, Matthew J Matasar, Paola Ghione
CHRONOS-4: Phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma. Blood advances (2024)
Pier Luigi Luigi Zinzani, Huaqing Wang, Jifeng Feng, Tae Min Kim, Rong Tao, Huilai Zhang, Laura Maria Fogliatto, Clara Maluquer Artigal, Muhit Özcan, Eduardo Patricio Yanez Ruiz, Won Seog Kim, Dmitry Kirtbaya, Iryna Kriachok, Felipe Maciel, Hongwei Xue, Krimo Bouabdallah, Charles Phelps, Shalini Chaturvedi, Anke Weispfenning, Peter N Morcos, Fatuma Catherine Atieno Odongo, Viktoriya Buvaylo, Barrett H Childs, Martin Dreyling, Matthew J Matasar, Paola Ghione
CHRONOS-4: Phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma. Blood advances (2024)
Chiara De Philippis, Cristina Zucchinetti, Daniele Mannina, Mauro Krampera, Pier Luigi Luigi Zinzani, Annalisa Chiappella, Alice di Rocco, Enrico Orcioulo, Maria Chiara Tisi, Flavio Pistolese, Laura Giordano, Armando Santoro, Stefania Bramanti
Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma. Bone marrow transplantation 59 (4) (2024)
Arianna Catelli, Cristina Nanni, Rita Mulè, Pier Luigi Luigi Zinzani, Sabattini Elena, Marcello Lanari, Francesca Conti
The Dark Side of Activated Phosphoinositide 3-Kinase-δ Syndrome 2: A Story Rewritten through FDG-PET. Journal of clinical medicine 13 (8) (2024)
Michael R Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji, Jacqueline Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Claire Dearden, Sascha Dietrich, Monica Else, Narendranath Epperla, Andrei Fagarasanu, Brunangelo Falini, Francesco Forconi, Alessandro Gozzetti, Paul Joseph Hampel, David J Hermel, Sunil Iyengar, James B Johnston, Gunnar Juliusson, Robert J Kreitman, Francesco Lauria, Gerard Lozanski, Christopher C Oakes, Sameer A Parikh, Jae H Park, Graeme Quest, Kanti R Rai, Farhad Ravandi, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Enrico Tiacci, Xavier Troussard, Bernhard J Woermann, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani
Hairy cell leukemia variant and WHO classification correspondence Re: 5 th edition WHO classification haematolymphoid tumors: lymphoid neoplasms. Leukemia (2024)
Criscuolo Marianna, Maria Elena Tosti, Alessandro Broccoli, Marzia Varettoni, Alessio Maria Edoardo Maraglino, Antonella Anastasia, Maria Cantonetti, Livio Trentin, Sofia Kovalchuk, Lorella Orsucci, Marina Deodato, Angelica Spolzino, Stefano Volpetti, Ombretta Annibali, Sergio Storti, Caterina Stelitano, Francesco Marchesi, Sonia Morè, Luana Fianchi, Brunangelo Falini, Alessandro Pulsoni, Enrico Tiacci, Pier Luigi Luigi Zinzani, Livio Pagano
Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review. Cancers 16 (8) (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie M Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances (2024)
Alessandro Broccoli, Lisa Argnani, Gabriele Gugliotta, Cinzia Pellegrini, Beatrice Casadei, Gianmarco Bagnato, Marianna Gentilini, Vittorio Stefoni, Pier Luigi Luigi Zinzani
The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous Transplantation. The oncologist 29 (6) (2024)
Martin Dreyling, Nathan Hale Fowler, Michael J Dickinson, Joaquin Martinez Lopez, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie L Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A Riedell, P Joy Ho, José Antonio Pérez-Simón, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh O'Donovan, Roberto Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update. Blood 143 (17) (2024)
Julia Driessen, Fer de Wit, Alex F Herrera, Pier Luigi Luigi Zinzani, Ann Steward LaCasce, Peter D Cole, Craig H Moskowitz, Miriam Santero, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée J M Zijlstra-Baalbergen, Barbara A Hutten, Alison J Moskowitz, Marie José Kersten
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis. Blood advances 8 (11) (2024)
Michael R Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji, Jacqueline Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Claire Dearden, Sascha Dietrich, Monica Else, Narendranath Epperla, Andrei Fagarasanu, Brunangelo Falini, Francesco Forconi, Alessandro Gozzetti, Paul Joseph Hampel, David J Hermel, Sunil Iyengar, James B Johnston, Gunnar Juliusson, Robert J Kreitman, Francesco Lauria, Gerard Lozanski, Christopher C Oakes, Sameer A Parikh, Jae H Park, Graeme Quest, Kanti R Rai, Farhad Ravandi, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Enrico Tiacci, Xavier Troussard, Bernhard J Woermann, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani
Hairy cell leukemia variant and WHO classification correspondence Re: 5 th edition WHO classification haematolymphoid tumors: lymphoid neoplasms. Leukemia 38 (7) (2024)
Tycel Jovelle Phillips, Abraham Avigdor, Ronit Gurion, Caterina Patti, Paolo Corradini, Monica Tani, Amitkumar Mehta, Izidore S Lossos, Pier Luigi Luigi Zinzani, Catherine Thieblemont, Wojciech Jurczak, Fred Zheng, Erica Rappold, Wanying Zhao, Ping Jiang, Peter W M Johnson
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204). Blood advances 8 (4) (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Annalisa Chiappella, Beatrice Casadei, Patrizia Chiusolo, Alice Di Rocco, Silva Ljevar, Martina Magni, Piera Angelillo, Anna Maria Barbui, Ilaria Cutini, Anna Dodero, Francesca Bonifazi, Maria Chiara Tisi, Stefania Bramanti, Maurizio Musso, Mirko Farina, Massimo Martino, Mattia Novo, Giovanni Grillo, Francesca Patriarca, Giulia Zacchi, Mauro Krampera, Martina Pennisi, Eugenio Galli, Maurizio Martelli, Andrés José Maria Ferreri, Silvia Ferrari, Riccardo Saccardi, Anisa Bermema, Anna Guidetti, Rosalba Miceli, Pier Luigi Luigi Zinzani, Paolo Corradini
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study. Leukemia (2024)
Francesca Romana Mauro, Alessandra Tedeschi, Marzia Varettoni, Francesca Romana Mauro, Giovanni Barosi, Pier Luigi Luigi Zinzani
Identifying and addressing unmet clinical needs on the use of zanubrutinib in chronic lymphocytic leukemia: A consensus-based position paper from an ad hoc expert panel. Hematological oncology 42 (2) (2024)
Annalisa Chiappella, Beatrice Casadei, Patrizia Chiusolo, Alice Di Rocco, Silva Ljevar, Martina Magni, Piera Angelillo, Anna Maria Barbui, Ilaria Cutini, Anna Dodero, Francesca Bonifazi, Maria Chiara Tisi, Stefania Bramanti, Maurizio Musso, Mirko Farina, Massimo Martino, Mattia Novo, Giovanni Grillo, Francesca Patriarca, Giulia Zacchi, Mauro Krampera, Martina Pennisi, Eugenio Galli, Maurizio Martelli, Andrés José Maria Ferreri, Silvia Ferrari, Riccardo Saccardi, Anisa Bermema, Anna Guidetti, Rosalba Miceli, Pier Luigi Luigi Zinzani, Paolo Corradini
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study. Leukemia 38 (5) (2024)
Tycel Jovelle Phillips, Abraham Avigdor, Ronit Gurion, Caterina Patti, Paolo Corradini, Monica Tani, Amitkumar Mehta, Izidore S Lossos, Pier Luigi Luigi Zinzani, Catherine Thieblemont, Wojciech Jurczak, Fred Zheng, Erica Rappold, Wanying Zhao, Ping Jiang, Peter W M Johnson
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204). Blood advances 8 (4) (2024)
Alessandro Broccoli, Lisa Argnani, Laura Nanni, Vittorio Stefoni, Cinzia Pellegrini, Beatrice Casadei, Gabriele Gugliotta, Matteo Carella, Paolo Elia Coppola, Gianmarco Bagnato, Pier Luigi Luigi Zinzani
Single-agent rituximab is an effective salvage therapy in pretreated hairy cell leukemia patients. Blood advances (2023)
Chun Liu, Pier Giorgio Cojutti, Maddalena Giannella, Marcello Roberto, Beatrice Casadei, Gianluca Cristiano, Cristina Papayannidis, Nicola Vianelli, Pier Luigi Luigi Zinzani, Pierluigi Viale, Francesca Bonifazi, Federico Pea
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study. Pharmaceutics 15 (3) (2023)
Zeno Pasquini, Alice Toschi, Beatrice Casadei, Cinzia Pellegrini, Alessandra D'Abramo, Serena Vita, Alessia Beccacece, Linda Bussini, Maria Clara Chionsini, Nicola Dentale, Alessia Cantiani, Tiziana Lazzarotto, Michele Bartoletti, Emanuele Nicastri, Pier Luigi Luigi Zinzani, Maddalena Giannella, Pierluigi Viale
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection. Hematological oncology (2023)
Tycel Jovelle Phillips, Abraham Avigdor, Ronit Gurion, Caterina Patti, Paolo Corradini, Monica Tani, Amitkumar Mehta, Izidore S Lossos, Pier Luigi Luigi Zinzani, Catherine Thieblemont, Wojciech Jurczak, Fred Zheng, Erica Rappold, Wanying Zhao, Ping Jiang, Peter W M Johnson
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204). Blood advances (2023)
Pier Luigi Luigi Zinzani, Armando Santoro, Giuseppe Gritti, Pauline Brice, Paul M Barr, John Kuruvilla, David Cunningham, Justin Kline, Nathalie A Johnson, Neha Mehta-Shah, Julie M Lisano, Rachael Wen, Alev Akyol, Alison J Moskowitz
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up. Blood advances (2023)
Emanuela Foglia, Elisabetta Garagiola, Vito Ladisa, Alessandro Rambaldi, Roberto Cairoli, Simona Sammassimo, Emanuela Omodeo Salè, Pier Luigi Luigi Zinzani, Marco Esposti, Luisa Alberti, Maria Franca Mulas, Eleonora Melis, Stefania Onnis, Maurizio Marcias, Vittorio Satta, Davide Croce
Multidimensional Results and Reflections on CAR-T: The Italian Evidence. International journal of environmental research and public health 20 (5) (2023)
Kai Rejeski, Marion Subklewe, Mahmoud Aljurf, Emmanuel Bachy, Adriana Cristina Balduzzi, Pere Barba, Benedetto Bruno, Reuben Benjamin, Matteo Giovanni Giovanni Carrabba, Christian Chabanon, Fabio Ciceri, Paolo Corradini, Julio Delgado, Roberta Di Blasi, Raffaella Greco, Houot Roch, Gloria Iacoboni, Ulrich Jäger, Marie José Kersten, Stephan Mielke, Arnon Nagler, Francesco Onida, Zinaida Peric, Claire Roddie, Annalisa Ruggeri, Fermin M Sanchez-Guijo, Isabel Sánchez-Ortega, Dominik Schneidawind, Maria-Luisa Schubert, John A Snowden, Catherine Thieblemont, Max S Topp, Pier Luigi Luigi Zinzani, John G Gribben, Chiara Bonini, Anna Sureda Balari, Ibrahim Yakoub Agha
Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations. Blood (2023)
Michael L Wang, Wojciech Jurczak, Pier Luigi Luigi Zinzani, Toby Andrew Eyre, Chan Yoon Y Cheah, Chaitra S Ujjani, Youngil Koh, Koji Izutsu, James N Gerson, Ian W Flinn, Benoît Tessoulin, Alvaro J Alencar, Shuo Ma, David John Lewis, Ewa Lech-Maranda, Joanna M Rhodes, Krish Patel, Kami Maddocks, Nicole Lamanna, Yucai Wang, Constantine S Tam, Tahla Munir, Hirokazu Nagai, Francisco Hernandez-Ilizaliturri, Anita Kumar, Timothy S Fenske, John Francis Seymour, Andrew D Zelenetz, Binoj Nair, Donald E Tsai, Minna Balbas, Richard A Walgren, Paolo Abada, Chunxiao Wang, Junjie Zhao, Anthony R Mato, Nirav N Shah
Pirtobrutinib in Covalent BTK-Inhibitor Pre-treated Mantle Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Juan Pablo Alderuccio, Isildinha M Reis, Mehdi Hamadani, Muthiah Nachiappan, Salman Leslom, Brad S Kahl, Weiyun Z Ai, John Radford, Melham M Solh, Kirit M Ardeshna, Brian T Hess, Matthew A Lunning, Pier Luigi Luigi Zinzani, Anastasios Stathis, Carmello Carlo-Stella, Izidore S Lossos, Paolo F Caimi, Sunwoo Han, Fei Yang, Russ A Kuker, Craig H Moskowitz
PET/CT-biomarkers enable risk stratification of patients with relapsed/refractory diffuse large B-cell lymphoma enrolled in the LOTIS-2 clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Gian Maria Asioli, Carlo Alberto Castioni, Pier Luigi Luigi Zinzani, Maria Chiara Casadio, Elisabetta Pierucci, Beatrice Casadei, Luca Spinardi, Cinzia Pellegrini, Massimiliano Bonafé, Enrico Maffini, Maria Guarino, Pietro Cortelli, Francesca Bonifazi
Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost! British journal of haematology 204 (3) (2023)
Pietro Quaglino, Nicola Pimpinelli, Pier Luigi Luigi Zinzani, Marco Paulli, Stefano Pileri, Emilio Berti, Lorenzo Cerroni, Joan Guitart, Youn H Kim, Serena Rupoli, Marco Santucci, Gabriele Simontacchi, Maarten Vermeer, Richard Hoppe, Barbara Pro, Steven H Swerdlow, Giovanni Barosi
Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel. Hematological oncology (2023)
Daniel Noerenberg, Franziska Briest, Cornelius Hennch, Kenichi Yoshida, Raphael Hablesreiter, Yasuhide Takeuchi, Hiroo Ueno, Annette M Staiger, Marita Ziepert, Fazila Asmar, Benjamin N Locher, Erika Tóth, Thomas Weber, Rose-Marie Amini, Wolfram Klapper, Maria Bouzani, Viola Poeschel, Andreas Rosenwald, Gerhard Held, Elias Campo, Naveed Ishaque, Kostas Stamatopoulos, George Kanellis, Ioannis Anagnostopoulos, Lars Bullinger, Neta Goldschmidt, Pier Luigi Luigi Zinzani, Csaba Bödör, Richard Rosenquist, Theodoros P Vassilakopoulos, German Ott, Seishi Ogawa, Frederik Damm
Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Mehdi Hamadani, Alexander I Spira, Xiaolei Zhou, Laura Liao, Lei Chen, John Radford, Weiyun Z Ai, Melhem M Solh, Kirit M Ardeshna, Brian T Hess, Paolo F Caimi, Anastasios Stathis, Carmelo Carlo Stella, Juan Pablo Alderuccio, Brad S Kahl, Ying Wang, Yajuan Gu Qin, Zhiying Cindy Xu, Pier Luigi Luigi Zinzani
Clinical Outcomes of Older and Younger Patients Treated with Loncastuximab Tesirine in the LOTIS-2 Clinical Trial. Blood advances (2023)
Pier Luigi Luigi Zinzani, Francesca Romana Mauro, Alessandra Tedeschi, Marzia Varettoni, Francesco Zaja, Giovanni Barosi
Unmet clinical needs in the use of zanubrutinib in malignant lymphomas (Waldenström macroglobulinemia, marginal zone lymphoma and mantle cell lymphoma): A consensus-based position paper from an ad hoc expert panel. Hematological oncology (2023)
Emmanuel Bachy, Kerry Joane Savage, Huiqiang Huang, Yok-Lam L Kwong, Giuseppe Gritti, Qingyuan Zhang, Anna Marina Liberati, Junning Cao, Hai-Yan Yang, Siguo Hao, Jianda Hu, Ke-Shu Zhou, Mario Petrini, Filomena Russo, Huilai Zhang, Wei Sang, Jie Ji, Andrés José Maria Ferreri, Gandhi Laurent Damaj, Wei Zhang, Hui Liu, Xiaoyan Ke, Chiara Ghiggi, Sha Huang, Xiaotong Li, Hui Yao, Jason C Paik, William Novotny, Wenxiao Zhou, Hongjie Zhu, Pier Luigi Luigi Zinzani
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open label phase 2 study. Blood advances (2023)
Francesco Peyronel, Julien Haroche, Campochiaro Corrado, Francesco Pegoraro, Zahir Amoura, Alessandro Tomelleri, Martina Mazzariol, Matthias Papo, Giulio Cavalli, Giuseppe Daniele Benigno, Paride Fenaroli, Chrysanthos Grigoratos, Maria Cecilia Mengoli, Arturo Bonometti, Emilio Berti, Gustavo Savino, Mauro Cives, Iria Neri, Gaetano Pacinella, Antonino Tuttolomondo, Massimo Marano, Francesco Muratore, Andreina Manfredi, Alessandro Broccoli, Pier Luigi Luigi Zinzani, Biagio Didona, Chiara Massaccesi, Andrea Buono, Enrico Ammirati, Vito Di Lernia, Lorenzo Dagna, Augusto Vaglio, Fleur Cohen-Aubart
EPIDEMIOLOGY AND GEOGRAPHIC CLUSTERING OF ERDHEIM-CHESTER DISEASE IN ITALY AND FRANCE. Blood (2023)
Emanuela Foglia, Elisabetta Garagiola, Vito Ladisa, Alessandro Rambaldi, Roberto Cairoli, Simona Sammassimo, Emanuela Omodeo Salè, Pier Luigi Luigi Zinzani, Marco Esposti, Luisa Alberti, Maria Franca Mulas, Eleonora Melis, Stefania Onnis, Maurizio Marcias, Vittorio Satta, Davide Croce
Multidimensional Results and Reflections on CAR-T: The Italian Evidence. International journal of environmental research and public health 20 (5) (2023)
Andrés José Maria Ferreri, Pier Luigi Luigi Zinzani, Carlo Messina, Diletta Valsecchi, Maria Chiara Rendace, Eleonora Premoli, Elisa Giacomini, Chiara Veronesi, Luca Degli Esposti, Paola Di Matteo
Burden of Illness in Follicular Lymphoma with Multiple Lines of Treatment, Italian RWE Analysis. Cancers 15 (17) (2023)
Philippe Armand, Pier Luigi Luigi Zinzani, Jee Hun Lee, Nathalie A Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A Shipp, Alex F Herrera, Jianxin Lin, Eunhee Kim, Samhita Chakraborty, Patricia Marinello, Craig H Moskowitz
Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy in relapsed/refractory classical Hodgkin lymphoma. Blood (2023)
Ginevra Lolli, Lisa Argnani, Guido Gini, Beatrice Casadei, Cinzia Pellegrini, Monica Tani, Eleonora Prete, Michele Cimminiello, Francesca Bonifazi, Pier Luigi Luigi Zinzani
Pixantrone as bridging therapy to allogeneic transplantation or in CAR T-cell pathway in patients with diffuse large B-cell lymphoma. Hematological oncology (2023)
Chun Liu, Pier Giorgio Cojutti, Maddalena Giannella, Marcello Roberto, Beatrice Casadei, Gianluca Cristiano, Cristina Papayannidis, Nicola Vianelli, Pier Luigi Luigi Zinzani, Pierluigi Viale, Francesca Bonifazi, Federico Pea
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study. Pharmaceutics 15 (3) (2023)
Gian Maria Asioli, Carlo Alberto Castioni, Pier Luigi Luigi Zinzani, Maria Chiara Casadio, Elisabetta Pierucci, Beatrice Casadei, Luca Spinardi, Cinzia Pellegrini, Massimiliano Bonafé, Enrico Maffini, Maria Guarino, Pietro Cortelli, Francesca Bonifazi
Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost! British journal of haematology (2023)
Gian Maria Asioli, Carlo Alberto Castioni, Pier Luigi Luigi Zinzani, Maria Chiara Casadio, Elisabetta Pierucci, Beatrice Casadei, Luca Spinardi, Cinzia Pellegrini, Massimiliano Bonafé, Enrico Maffini, Maria Guarino, Pietro Cortelli, Francesca Bonifazi
Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost! British journal of haematology 204 (3) (2023)
Gian Maria Asioli, Carlo Alberto Castioni, Pier Luigi Luigi Zinzani, Maria Chiara Casadio, Elisabetta Pierucci, Beatrice Casadei, Luca Spinardi, Cinzia Pellegrini, Massimiliano Bonafé, Enrico Maffini, Maria Guarino, Pietro Cortelli, Francesca Bonifazi
Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost! British journal of haematology (2023)
Mehdi Hamadani, Morton Coleman, Ralph Boccia, Juraj Duras, Martin Hutchings, Pier Luigi Luigi Zinzani, Raul Cordoba, Mariana Bastos Oreiro, Vanessa Williams, Huiqing Liu, Michael Stouffs, Peter Langmuir, Juan-Manuel Sancho
Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL-102): A phase 1 study. Hematological oncology (2023)
Pier Luigi Luigi Zinzani, Jiří Mayer, Christopher R Flowers, Fontanet Bijou, Ana C Oliveira, Yuqin Song, Qingyuan Zhang, Michele Merli, Krimo Bouabdallah, Peter Ganly, Huilai Zhang, Roderick Johnson, Alejandro Martin Martin Garcia-Sancho, Mariano Provencio Pulla, Marek Trněný, Sam Yuen, Herve Tilly, Edwin Kingsley, Gayane Tumyan, Sarit E Assouline, Rebecca Auer, Elena Ivanova, Pil Kim, Sha Huang, Richard Delarue, Judith Trotman
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Stephen Samuel Opat, Alessandra Tedeschi, Bei Hu, Kim M Linton, Pamela McKay, Sophie Leitch, Morton Coleman, Pier Luigi Luigi Zinzani, Jie Jin, Mingyuan Sun, Magdalena Sobieraj-Teague, Peter J Browett, Xiaoyan Ke, Catherine Thieblemont, Kirit M Ardeshna, Fontanet Bijou, Patricia A Walker, Eliza A Hawkes, Shir Jing Ho, Ke-Shu Zhou, Zhiyu Liang, Jianfeng Xu, Chris Tankersley, Richard Delarue, Melannie Co, Judith Trotman
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study. Blood advances (2023)
Malgorzata Mikulska, Diletta Testi, Chiara Russo, Elisa Balletto, Chiara Sepulcri, Linda Bussini, Chiara Dentone, Federica Magne, Sílvia Policarpo, Caterina Campoli, Filippo Miselli, Alessandro Cilli, Chiara Ghiggi, Sara Aquino, Carmen Di Grazia, Maddalena Giannella, Daniele Roberto Giacobbe, Antonio Vena, Anna Maria Raiola, Francesca Bonifazi, Pier Luigi Luigi Zinzani, Michele Cavo, Roberto M Lemoli, Emanuele Angelucci, Pierluigi Viale, Matteo Bassetti, Michele Bartoletti
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders. British journal of haematology (2023)
Stephen M Ansell, Paul J Bröckelmann, Gottfried von Keudell, Jee Hun Lee, Armando Santoro, Pier Luigi Luigi Zinzani, Graham P Collins, Jonathon B Cohen, Jan Paul de Boer, John Kuruvilla, Kerry Joane Savage, Marek Trněný, Mariano Provencio, Ulrich Jäger, Wolfgang Willenbacher, Rachael Wen, Alev Akyol, Joanna Mikita-Geoffroy, Margaret A Shipp, Andreas Michael Engert, Philippe Armand
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from pivotal phase 2 CheckMate 205 study. Blood advances (2023)
Emanuela Foglia, Elisabetta Garagiola, Vito Ladisa, Alessandro Rambaldi, Roberto Cairoli, Simona Sammassimo, Emanuela Omodeo Salè, Pier Luigi Luigi Zinzani, Marco Esposti, Luisa Alberti, Maria Franca Mulas, Eleonora Melis, Stefania Onnis, Maurizio Marcias, Vittorio Satta, Davide Croce
Multidimensional Results and Reflections on CAR-T: The Italian Evidence. International journal of environmental research and public health 20 (5) (2023)
Chun Liu, Pier Giorgio Cojutti, Maddalena Giannella, Marcello Roberto, Beatrice Casadei, Gianluca Cristiano, Cristina Papayannidis, Nicola Vianelli, Pier Luigi Luigi Zinzani, Pierluigi Viale, Francesca Bonifazi, Federico Pea
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study. Pharmaceutics 15 (3) (2023)
Pier Luigi Luigi Zinzani, Catherine Thieblemont, Vladimir Melnichenko, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Maria Fogliatto, Alejandro Martin Martin Garcia-Sancho, Beth Christian, Zafer Gulbas, Muhit Özcan, Guilherme Fleury Perini, Herve Ghesquieres, Margaret A Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand
Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma: Final Analysis of KEYNOTE-170. Blood (2023)
Carmelo Carlo-Stella, Pier Luigi Luigi Zinzani, Anna Sureda, Luis Araújo, Olivier Casasnovas, Cecilia Carpio, Su-Peng Yeh, Krimo Bouabdallah, Guillaume Cartron, Won Seog Kim, Raul Cordoba, Youngil Koh, Alessandro Re, Daniela Alves, Martine Chamuleau, Steven Le Gouill, Armando López-Guillermo, Ilídia Moreira, Marjolein W M van der Poel, Giovanni Abbadessa, Robin Meng, Ran Ji, Lucie Lépine, Rao Saleem, Vincent Ribrag
A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma. Hematological oncology (2022)
Ginevra Lolli, Margherita Ursi, Michele Dicataldo, Beatrice Casadei, Gianluca Storci, Lisa Argnani, Francesca Bonifazi, Pier Luigi Luigi Zinzani
Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient. Leukemia & lymphoma 63 (12) (2022)
Mark Bishton, Scott Marshall, Jatinder Harchowal, Gilles Salles, Camille Golfier, Alessandra Tucci, Alicia Rodriguez Fernández, Jose Javier Sanchez Blanco, Monica Bocchia, SooKyoung Kim, Young Nam Lee, Pier Luigi Luigi Zinzani
The safety and clinical effectiveness of rapid infusion with CT-P10 in patients with non-Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non-interventional post-authorization safety study in Europe. Hematological oncology 40 (3) (2022)
Vittorio Stefoni, Lisa Argnani, Matteo Carella, Beatrice Casadei, Alice Morigi, Ginevra Lolli, Alessandro Broccoli, Cinzia Pellegrini, Laura Nanni, Paolo Elia Coppola, Pier Luigi Luigi Zinzani
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience. Journal of cancer research and clinical oncology (2022)
Steven M Horwitz, Julia J Scarisbrick, Reinhard Dummer, Sean Whittaker, Madeleine Duvic, Youn H Kim, Pietro Quaglino, Pier Luigi Luigi Zinzani, Oliver Bechter, Herbert Eradat, Lauren Pinter-Brown, Oleg E Akilov, Larisa Geskin, Jose Antonio Sanches, Pablo Luis Ortiz-Romero, Michael Weichenthal, David C Fisher, Jan Walewski, Judith Trotman, Kerry Taylor, Stephane Dalle, Rudolf Stadler, Julie Lisano, Veronica Bunn, Meredith Little, Henry Miles Prince
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data. Blood advances 5 (23) (2022)
Laurence L de Leval, Ash A Alizadeh, Peter Leif Bergsagel, Elias Campo, Andrew John Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M Horwitz, Ari M Melnick, William George Morice, Ryan D Morin, Bertrand Nadel, Stefano A Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P Treon, Andrew D Zelenetz, Ranjana H Advani, Carl E Allen, Stephen M Ansell, Wing C John Chan, James R Cook, Lucy B M Cook, Francesco d'Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G Gribben, Olivier Hermine, Daniel James Hodson, Eric D Hsi, Giorgio Ga Inghirami, Elaine S Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L King, Young-Hyeh Ko, Ann Steward LaCasce, Georg Lenz, José I Martin-Subero, Miguel Angel Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-Fend, Scott J Rodig, Andreas Rosenwald, Gilles Andre Salles, Jesús San F Miguel, Kerry Joane Savage, Laurie Helen Sehn, Gianpietro C Semenzato, Louis M Staudt, Steven Howard Swerdlow, Constantine S Tam, Judith Trotman, Julie M Vose, Oliver Weigert, Wyndham H Wilson, Jane N Winter, Catherine J Wu, Pier Luigi Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W Scott
Genomic profiling for clinical decision making in lymphoid neoplasms. Blood 140 (21) (2022)
Vittorio Stefoni, Cinzia Pellegrini, Lisa Argnani, Paolo Corradini, Anna Dodero, Lorella Orsucci, Stefano Volpetti, Pier Luigi Luigi Zinzani
Brentuximab vedotin in the treatment of relapsed/refractory CD30+ peripheral T-cell lymphoma: A FIL phase 2 study. Hematological oncology 40 (2) (2022)
Angie Mae Rodday, Susan K Parsons, Jenica N Upshaw, Jonathan W Friedberg, Andrea Gallamini, Eliza A Hawkes, David C Hodgson, Peter W M Johnson, Brian L Link, Eric Mou, Kerry Joane Savage, Pier Luigi Luigi Zinzani, Matthew John Maurer, Andrew M Evens
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard J Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Pier Luigi Luigi Zinzani, Maurizio Martelli, Simone Ferrero, Massimo Gentile, Luca Laurenti, Francesca Romana Mauro, Paolo Sportoletti, Alessandra Tedeschi, Marzia Varettoni, Chiara Rusconi
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement. Hematological oncology 40 (4) (2022)
Kerry Joane Savage, Steven M Horwitz, Ranjana Advani, Jacob Haaber Christensen, Eva Domingo-Domenech, Giuseppe Rossi, Judith Trotman, Onder Alpdogan, Cheolwon Suh, Kensei Tobinai, Andrei Shustov, Marek Trněný, Sam Yuen, Pier Luigi Luigi Zinzani, Lorenz Trümper, Tim Ilidge, Owen A O'Connor, Barbara Pro, Harry Miao, Veronica Bunn, Keenan Fenton, Michelle Fanale, Markus Puhlmann, Swaminathan Iyer
Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2. Blood advances 6 (19) (2022)
Juan Pablo Alderuccio, Luca Arcaini, Marcus P Watkins, Anne W Beaven, Geoffrey Shouse, Narendranath Epperla, Michele Spina, Alexandra Stefanovic, Jose Sandoval-Sus, Pallawi Torka, Ash B Alpert, Adam J Olszewski, Seo-Hyun Kim, Brian Hess, Sameh Gaballa, Sabarish Ayyappan, Jorge J Castillo, Lisa Argnani, Timothy J Voorhees, Raya Saba, Sayan Mullick Chowdhury, Fernando Vargas, Isildinha M Reis, Deukwoo Kwon, Jonathan Struan Alexander, Wei Zhao, Dali Edwards, Peter Martin, Emanuele Cencini, Manali Kamdar, Brian L Link, Constantine N Logothetis, Alex F Herrera, Jonathan W Friedberg, Brad S Kahl, Stefano Luminari, Pier Luigi Luigi Zinzani, Izidore S Lossos
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma. Blood advances 6 (7) (2022)
Simone Ferrero, Massimo Gentile, Luca Laurenti, Francesca Romana Mauro, Maurizio Martelli, Paolo Sportoletti, Chiara Rusconi, Pier Luigi Luigi Zinzani, Alessandra Tedeschi, Marzia Varettoni
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement. Hematological oncology 40 (3) (2022)
Mark J Bishton, Gilles Salles, Camille Golfier, Wolfgang Knauf, Monica Bocchia, Deborah Turner, Borhane Slama, Jatinder Harchowal, Scott Marshall, Alberto Bosi, Juan José Bargay Lleonart, Manfred Welslau, SooKyoung Kim, Young Nam Lee, Pier Luigi Luigi Zinzani, Kamel Laribi
Real-world clinical effectiveness and safety of CT-P10 in patients with diffuse large B-cell lymphoma: An observational study in Europe. EJHaem 4 (1) (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard J Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard J Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Elias Campo, Elaine S Jaffe, James R Cook, Leticia Quintanilla-Fend, Steven H Swerdlow, Kenneth C Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Dogan, Andrew L Feldman, Falko Fend, Jonathan W Friedberg, Philippe Gaulard, Paolo Ghia, Steven M Horwitz, Rebecca L King, Gilles Andre Salles, Jesús San F Miguel, John Francis Seymour, Steven P Treon, Julie M Vose, Emanuele Zucca, Ranjana Advani, Stephen Ansell, Wing-Yan Au, Carlos Barrionuevo, Peter Leif Bergsagel, Wing C Chan, Jeffrey I Cohen, Francesco d'Amore, Andrew John Davies, Brunangelo Falini, Irene M Ghobrial, Mariusz A Wasik, John G Gribben, Eric D Hsi, Brad S Kahl, Won-Seog Kim, Shaji K Kumar, Ann Steward LaCasce, Camille Laurent, Georg Lenz, John P Leonard, Michael P Link, Armando Lopez-Guillermo, Maria-Victoria Mateos-Manteca, Elizabeth A Macintyre, Ari M Melnick, Judith Trotman, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano A Pileri, Miguel Angel Piris, Barbara Pro, Vincent Rajkumar, Steven T Rosen, Birgitta Sander, Laurie Sehn, Margaret A Shipp, Sonali M Smith, Louis M Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H Wilson, Tadashi Yoshino, Pier Luigi Luigi Zinzani, Martin Dreyling, David W Scott, Jane N Winter, Andrew D Zelenetz
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140 (11) (2022)
Gloria Iacoboni, Kai Rejeski, Guillermo Villacampa, Jaap A van Doesum, Annalisa Chiappella, Francesca Bonifazi, Lucía López Corral, Michiel van Aalderen, Mi Kwon, Nuria Martínez-Cibrian, Stefania Bramanti, Juan Luis Reguera-Ortega, Lina Camacho-Arteaga, Christian Schmidt, Ana Marín-Niebla, Marie José Kersten, Alejandro Martin Martin Garcia-Sancho, Pier Luigi Luigi Zinzani, Paolo Corradini, Tom van Meerten, Marion Subklewe, Pere Barba
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma. Blood advances 6 (12) (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard J Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Beatrice Casadei, Lisa Argnani, Alessandro Broccoli, Caterina Patti, Piero Maria Stefani, Antonio Cuneo, Gloria Margiotta Casaluci, Chiara Rusconi, Guido Gini, Fabrizio Pane, Francesco D'Alò, Debora Luzi, Maria Cantonetti, Samantha Pozzi, Gerardo Musuraca, Chiara Rosignoli, Annalisa Arcari, Sofya Kovalchuk, Monica Tani, Maria Chiara Tisi, Mario Petrini, Vittorio Stefoni, Pier Luigi Luigi Zinzani
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study. Cancers 14 (3) (2022)
Mark J Bishton, Gilles Salles, Camille Golfier, Wolfgang Knauf, Monica Bocchia, Deborah Turner, Borhane Slama, Jatinder Harchowal, Scott Marshall, Alberto Bosi, Juan José Bargay Lleonart, Manfred Welslau, SooKyoung Kim, Young Nam Lee, Pier Luigi Luigi Zinzani, Kamel Laribi
Real-world clinical effectiveness and safety of CT-P10 in patients with diffuse large B-cell lymphoma: An observational study in Europe. EJHaem 4 (1) (2022)

Pier Luigi Luigi Zinzani.css-eqlu8i{font-size:small;padding-left:4px;} (Pierluigi Luigi Zinzani, P L Zinzani, PierLuigi Zinzani, Pier L Zinzani, Pierluigi Zinzani, Pier Luigi Zinzani, Pier-Luigi Zinzani)

Publication Activity (10 Years)

Top Topics

Top Venues

Pier Luigi Luigi Zinzani (Pierluigi Luigi Zinzani, P L Zinzani, PierLuigi Zinzani, Pier L Zinzani, Pierluigi Zinzani, Pier Luigi Zinzani, Pier-Luigi Zinzani)